{"archive_url":"https://www.ebi.ac.uk/ega/datasets/EGAD00001002400","experiment":{"EXPERIMENT_TYPE":"Histone H3K27ac","EXPERIMENT_ID":"EGAX00001365837","attributes":{"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["\"7 min; 30 sec ON/ 30 sec OFF\""],"CHIP_ANTIBODY":["H3K27ac"],"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A"],"CHIP_PROTOCOL_BEAD_AMOUNT":["20 ul"],"EXPERIMENT_TYPE":["Histone H3K27ac"],"CHIP_ANTIBODY_CATALOG":["BP grade"],"CHIP_ANTIBODY_LOT":["A1723-0041d"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["1,0 ug"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["1x 500.000 cells = 33 ul"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked 10 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Protocol July 2014: 500.000 cells per ChIP. Overnight incubation of chromatin with antibody. 1 hour incubation in the morning with A/G magnetic beads. Wash once with buffer 1, and twice with buffer 2 and 3 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"LIBRARY_GENERATION_FRAGMENT_SIZE_RANGE":["229"],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor Pico (UCD-600)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"EGA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/capillary_blood/T9C/T-cell_Acute_Lymphocytic_Leukemia/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigWig","SIZE":"538M","NAME":"S01PV8H1.ERX1305347.H3K27ac.bwa.GRCh38.20160226.bw","FILE_TYPE":"CHIP_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/capillary_blood/T9C/T-cell_Acute_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S01PV8H1.ERX1305347.H3K27ac.bwa.GRCh38.20160226.bw","PROTOCOL_DOC":"chip_seq_grch38","MD5":"578f524bcee40c083ae02fc0b4f3926c"},{"FORMAT":"bigBed","SIZE":"2.0M","NAME":"S01PV8H1.ERX1305347.H3K27ac.bwa.GRCh38.20160310.bb","FILE_TYPE":"CHIP_MACS2_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/capillary_blood/T9C/T-cell_Acute_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S01PV8H1.ERX1305347.H3K27ac.bwa.GRCh38.20160310.bb","PROTOCOL_DOC":"chip_seq_grch38","MD5":"a0a39b436b8797c33322176fe9a5313c"},{"FORMAT":"BED","SIZE":"2.2M","NAME":"S01PV8H1.ERX1305347.H3K27ac.bwa.GRCh38.20160310.bed.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/capillary_blood/T9C/T-cell_Acute_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S01PV8H1.ERX1305347.H3K27ac.bwa.GRCh38.20160310.bed.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"0c2c67fc2e491825b21d3fa0b5825759"},{"FORMAT":"Text","SIZE":"2.5M","NAME":"S01PV8H1.ERX1305347.H3K27ac.bwa.GRCh38.20160310.xls.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/capillary_blood/T9C/T-cell_Acute_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S01PV8H1.ERX1305347.H3K27ac.bwa.GRCh38.20160310.xls.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"d7f1e39fdec95a4d43a2e7dffe3db874"}],"dataset_id":"EGAD00001002400","sample":{"SAMPLE_SOURCE":"capillary blood","SAMPLE_NAME":"T9C","sample_barcode":"S01PV8H1","attributes":{"DONOR_HEALTH_STATUS":["T-cell Acute Lymphocytic Leukemia"],"DONOR_AGE":["20 - 25"],"MOLECULE":["genomic DNA"],"DISEASE":["T-cell Acute Lymphocytic Leukemia"],"BIOMATERIAL_PROVIDER":["Necker's hospital"],"BIOMATERIAL_TYPE":["Primary Tissue"],"TISSUE_TYPE":["capillary blood"],"DISEASE_ONTOLOGY_URI":[{"url":"9","label":"C0023449"}],"SUBJECT_ID":["T9C"],"SAMPLE_ONTOLOGY_URI":[{"url":"7","label":"UBERON_0013757"}],"GENDER":["female"],"DONOR_ID":["T9C"],"DONOR_SEX":["Female"],"PASSAGE_IF_EXPANDED":["none"]},"SAMPLE_ID":"EGAN00001358211","SAMPLE_DESCRIPTION":"T-cell Acute Lymphocytic Leukemia"}}